117 related articles for article (PubMed ID: 35395477)
1. Ultrasound-triggered reactive oxygen species effector nanoamplifier for enhanced combination therapy of mutant p53 tumors.
Wang X; Song K; Fan Y; Du J; Liu J; Xu J; Zheng L; Ouyang R; Li Y; Miao Y; Zhang D
Colloids Surf B Biointerfaces; 2022 Jul; 215():112489. PubMed ID: 35395477
[TBL] [Abstract][Full Text] [Related]
2. Light-Elicited and Oxygen-Saved Iridium Nanocapsule for Oxidative Damage Intensified Oncotherapy.
Chen G; Wang X; He Z; Li X; Yang Z; Zhang Y; Li Y; Zheng L; Miao Y; Zhang D
Molecules; 2023 May; 28(11):. PubMed ID: 37298873
[TBL] [Abstract][Full Text] [Related]
3. Protoporphyrin-sensitized degradable bismuth nanoformulations for enhanced sonodynamic oncotherapy.
Song K; Chen G; He Z; Shen J; Ping J; Li Y; Zheng L; Miao Y; Zhang D
Acta Biomater; 2023 Mar; 158():637-648. PubMed ID: 36621634
[TBL] [Abstract][Full Text] [Related]
4. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.
Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C
Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924
[TBL] [Abstract][Full Text] [Related]
5. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma.
Huang X; Chen J; Wu W; Yang W; Zhong B; Qing X; Shao Z
Acta Biomater; 2020 Jun; 109():229-243. PubMed ID: 32294550
[TBL] [Abstract][Full Text] [Related]
6. MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good?
Abbas HHK; Alhamoudi KMH; Evans MD; Jones GDD; Foster SS
BMC Cancer; 2018 Apr; 18(1):423. PubMed ID: 29661172
[TBL] [Abstract][Full Text] [Related]
7. Comparison of protoporphyrin IX produced cell proliferation inhibition between human breast cancer MCF-7 and MDA-MB-231 cells.
Li L; Chen Y; Wang X; Feng X; Wang P; Liu Q
Pharmazie; 2014 Aug; 69(8):621-8. PubMed ID: 25158574
[TBL] [Abstract][Full Text] [Related]
8. Broaden sources and reduce expenditure: Tumor-specific transformable oxidative stress nanoamplifier enabling economized photodynamic therapy for reinforced oxidation therapy.
Xu X; Huang B; Zeng Z; Chen J; Huang Z; Guan Z; Chen M; Huang Y; Zhao C
Theranostics; 2020; 10(23):10513-10530. PubMed ID: 32929363
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species.
Kalo E; Kogan-Sakin I; Solomon H; Bar-Nathan E; Shay M; Shetzer Y; Dekel E; Goldfinger N; Buganim Y; Stambolsky P; Goldstein I; Madar S; Rotter V
J Cell Sci; 2012 Nov; 125(Pt 22):5578-86. PubMed ID: 22899716
[TBL] [Abstract][Full Text] [Related]
10. A synthetic chalcone derivative, 2-hydroxy-3',5,5'-trimethoxychalcone (DK-139), triggers reactive oxygen species-induced apoptosis independently of p53 in A549 lung cancer cells.
Gil HN; Jung E; Koh D; Lim Y; Lee YH; Shin SY
Chem Biol Interact; 2019 Jan; 298():72-79. PubMed ID: 30408460
[TBL] [Abstract][Full Text] [Related]
11. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK-CHOP-death receptor pathway.
Gupta SC; Francis SK; Nair MS; Mo YY; Aggarwal BB
J Biol Chem; 2013 Nov; 288(45):32343-32356. PubMed ID: 24078627
[TBL] [Abstract][Full Text] [Related]
12. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress.
Kostecka A; Sznarkowska A; Meller K; Acedo P; Shi Y; Mohammad Sakil HA; Kawiak A; Lion M; Królicka A; Wilhelm M; Inga A; Zawacka-Pankau J
Cell Death Dis; 2014 Oct; 5(10):e1484. PubMed ID: 25341038
[TBL] [Abstract][Full Text] [Related]
13. Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage.
Lee MS; Yaar M; Eller MS; Rünger TM; Gao Y; Gilchrest BA
J Dermatol Sci; 2009 Dec; 56(3):154-62. PubMed ID: 19906512
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminolevulinic Acid Enhances Ultrasound-mediated Antitumor Activity via Mitochondrial Oxidative Damage in Breast Cancer.
Shimamura Y; Tamatani D; Kuniyasu S; Mizuki Y; Suzuki T; Katsura H; Yamada H; Endo Y; Osaki T; Ishizuka M; Tanaka T; Yamanaka N; Kurahashi T; Uto Y
Anticancer Res; 2016 Jul; 36(7):3607-12. PubMed ID: 27354630
[TBL] [Abstract][Full Text] [Related]
15. MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways.
Patel A; Burton DG; Halvorsen K; Balkan W; Reiner T; Perez-Stable C; Cohen A; Munoz A; Giribaldi MG; Singh S; Robbins DJ; Nguyen DM; Rai P
Oncogene; 2015 May; 34(20):2586-96. PubMed ID: 25023700
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of tanshinone IIA and andrographolide on the apoptosis of cancer cells via crosstalk between p53 and reactive oxygen species pathways.
Li Y; Jiang B; Wang R; Wang J; Li Y; Bao Y
Pharmacol Rep; 2020 Apr; 72(2):400-417. PubMed ID: 32048269
[TBL] [Abstract][Full Text] [Related]
17. Gallium compound GaQ(3) -induced Ca(2+) signalling triggers p53-dependent and -independent apoptosis in cancer cells.
Gogna R; Madan E; Keppler B; Pati U
Br J Pharmacol; 2012 May; 166(2):617-36. PubMed ID: 22074401
[TBL] [Abstract][Full Text] [Related]
18. Augment of Oxidative Damage with Enhanced Photodynamic Process and MTH1 Inhibition for Tumor Therapy.
Hu JJ; Chen Y; Li ZH; Peng SY; Sun Y; Zhang XZ
Nano Lett; 2019 Aug; 19(8):5568-5576. PubMed ID: 31262183
[TBL] [Abstract][Full Text] [Related]
19. Influence of induced reactive oxygen species in p53-mediated cell fate decisions.
Macip S; Igarashi M; Berggren P; Yu J; Lee SW; Aaronson SA
Mol Cell Biol; 2003 Dec; 23(23):8576-85. PubMed ID: 14612402
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model.
Suehiro S; Ohnishi T; Yamashita D; Kohno S; Inoue A; Nishikawa M; Ohue S; Tanaka J; Kunieda T
J Neurosurg; 2018 Dec; 129(6):1416-1428. PubMed ID: 29350596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
